Acquisition broadens Roche reach in diagnostics
Roche Group has spent $600 million to buy full ownership of BioVeris Corp. of Gaithersburg, Md., gaining control of BioVeris’ diagnostic technology. The Swiss company’s U.S. subsidiary, Indianapolis-based Roche Diagnostics, had licensed the electrochemiluminescence technology in machines it sold to hospitals and commercial laboratories—but was limited to diagnosing human diseases. The acquisition, which is expected […]